Diagnostic performance of MSCT in cardiomyopathy patients

Diagnostic performance of MSCT in cardiomyopathy patients - MSCT in cardiomyopathy patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30959

Enrollment

Registered

2007-09-21

Start date

2007-10-10

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary atherosclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - patient is symptomatic - LVEF 60 mm./ female >55 mm.). - cardiomyopathy of unknown origin (ischemic/non-ischemic). - willing to participate. - signed a written consent form approved by the ethical committee of Erasmus MC. - MSCT possible within two months before invasive angiography.

Exclusion criteria

Exclusion criteria: - intolerance for Iodine. - creatinine level >120. - coronary stent placement or bypass grafting in the past. - known myocardial infarction - pregnancy - not being able to breath hold for 15 seconds. - under the age of twenty - being incapacitated - acute patients

Design outcomes

Primary

Measure	Time frame
Diagnostic performance of MSCT will be demonstrated in terms of specificity, sensitivity, PPV, NPV and accuracy. ICA will be used as the standard of reference. For the MSCT a combination of calcium scoring (first) and coronary angiography (second) will be performed.	—

Countries

Netherlands

Outcome results